Sigma Healthcare Limited
Simbolis: SIG.AX
ASX
1.295
AUDRinkos kaina šiandien
447.5904
P/E santykis
3.5707
PEG koeficientas
1.95B
MRK kapitalizacija
- 0.01%
DIV pajamingumas
Sigma Healthcare Limited (SIG-AX) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 356.5 | 16.6 | 31.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 320 | 337.4 | 358.7 | |||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 221.1 | 324.9 | 321.6 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 14.9 | 6.9 | 50.1 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 912.5 | 685.8 | 761.6 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 271.8 | 290.9 | 281.6 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 89.1 | 95.2 | 103 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 20 | 118.2 | 128.1 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 109.1 | 213.5 | 231 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 21.3 | 17.4 | 18.4 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 88.3 | 89.2 | 85.8 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 1.2 | -95.2 | -103 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 491.6 | 515.8 | 513.8 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 1404.1 | 1201.6 | 1275.4 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 303.4 | 406 | 352.3 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 9.8 | 12.9 | 25.7 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 126.8 | 80 | 165 | |||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 134 | 132.7 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 58 | 57.4 | 77.8 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 160.2 | 246.5 | 329 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 126.8 | 134 | 132.7 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 531.5 | 723.8 | 786.7 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 1682.4 | 1286.1 | 1286.1 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -769.2 | -761.6 | -741.1 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 2.9 | 3 | 2.9 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -45.3 | -51.7 | -60.7 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 870.8 | 475.9 | 487.2 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1404.1 | 1201.6 | 1275.4 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 1.8 | 1.8 | 1.6 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 872.6 | 477.8 | 488.8 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||
Total Investments | 0 | 21.3 | 17.4 | 18.4 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 136.6 | 227 | 323.4 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | -219.9 | 210.3 | 292.3 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 4.5 | 1.8 | -7.2 | ||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 28.3 | 30.3 | 27.7 | ||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -2.8 | 15.2 | -65.7 | ||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 2.8 | 1.9 | 0 | ||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 16.3 | 87.2 | -76.1 | ||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 10.9 | 27.5 | -30.7 | ||||||||||||||||||||||
cash-flows.row.inventory | 0 | 103.7 | -3.2 | 27.5 | ||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -102.7 | 53.5 | -7.1 | ||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 4.3 | 9.3 | -65.8 | ||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -7.2 | 6.3 | 75.1 | ||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -4.7 | -29.4 | -14.2 | ||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 8.9 | 0.5 | 0 | ||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -10.5 | -0.8 | -2.4 | ||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 1.5 | 0.3 | 0 | ||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 10.5 | 0.8 | 0 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 5.7 | -28.6 | -16.6 | ||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -80 | -85 | -165 | ||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 396.1 | 0.9 | 0.2 | ||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -9.5 | -16.9 | -165.2 | ||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -10.8 | -15 | -19.9 | ||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -0.8 | -1 | 478.8 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 295.8 | -116.9 | 128.9 | ||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 339.8 | -14.5 | 15 | ||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 356.5 | 16.6 | 31.1 | ||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 16.6 | 31.1 | 16.1 | ||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 42 | 142.7 | -46.3 | ||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -4.7 | -29.4 | -14.2 | ||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 37.2 | 113.3 | -60.5 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 3322.1 | 3660.2 | 3446.2 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 3132.2 | 3436.2 | 3246.7 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 189.8 | 224.1 | 199.4 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 41.4 | 101.7 | 44.7 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 261.8 | 293 | 309.6 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 3394 | 3729.2 | 3556.3 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 1.7 | 0.6 | 0.2 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 16.3 | 14.4 | 10.8 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 80.6 | 74.4 | 101.9 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 41.4 | 101.7 | 44.7 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 80.6 | 74.4 | 101.9 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 16.3 | 14.4 | 10.8 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 28.3 | 30.3 | 27.7 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | -71.9 | -68.9 | -110.2 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 8.6 | 5.5 | -8.3 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 3.3 | 2.4 | -2 | |||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 4.5 | 1.8 | -7.2 |
Dažnai užduodami klausimai
Kas yra Sigma Healthcare Limited (SIG.AX) bendras turtas?
Sigma Healthcare Limited (SIG.AX) bendras turtas yra 1404133000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.057.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 0.024.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.001.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra -0.022.
Kas yra Sigma Healthcare Limited (SIG.AX) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 4509000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 136631000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 261767000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.